I haven't heard of this before, and didn't see it on the company's website.
A Study in Multiple Sclerosis Patients to Determine the Safety of Different Doses of A4I Compared to Placebo and Their Effects on Multiple Sclerosis Lesions
This study is not yet open for patient recruitment.
Verified by Hoffmann-La Roche June 2006
Sponsored by: Hoffmann-La Roche
Information provided by: Hoffmann-La Roche
The purpose of this study is to determine the safety and the effects of different doses of an investigational compound A4I compared to placebo. Throughout the study participants will be evaluated by Magnetic Resonance Imaging (MRI) scans to determine the effects of the drug on Multiple Sclerosis lesions.
Study start: April 2005
http://www.clinicaltrials.gov/ct/show/N ... 3?order=55